FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893952249> ?p ?o ?g. }

• W2893952249 endingPage "175628481880030" @default.
• W2893952249 startingPage "175628481880030" @default.
• W2893952249 abstract "Background: Cirrhosis-related complications are associated with poor prognosis. With our analyses, we examined the potential benefit of rifaximin in reducing the risk of developing cirrhosis-related complications. Methods: Adults with cirrhosis and hepatic encephalopathy (HE) in remission were randomly assigned to receive rifaximin 550 mg twice daily or placebo for 6 months with concomitant lactulose permitted. Post hoc analyses examined time to cirrhosis-related complications (HE, spontaneous bacterial peritonitis (SBP), variceal bleeding, acute kidney injury/hepatorenal syndrome). Subgroup analyses evaluated efficacy for select baseline disease characteristics. Results: Of patients receiving rifaximin ( n = 140) and placebo ( n = 159), 53.6% and 49.1%, respectively, had baseline Model for End-Stage Liver Disease (MELD) score ⩾ 12 and international normalized ratio (INR) ⩾ 1.2. Baseline ascites was observed in 36.4% (rifaximin) and 34.6% (placebo) of patients. In patients with MELD score ⩾ 12 and INR ⩾ 1.2, rifaximin reduced the relative risk (RR) of any first complication experienced during trial by 59% [hazard ratio (HR) = 0.41, 95% confidence interval (CI): 0.25–0.67; p < 0.001] versus placebo. For patients with baseline ascites, rifaximin reduced the RR of any first complication experienced during trial by 42% versus placebo (HR = 0.58, 95% CI: 0.34–1.0; p = 0.045). For some subgroups, there was a decrease in RR of complications of SBP, variceal bleeding, and acute kidney injury/hepatorenal syndrome with rifaximin versus placebo, although there were few events reported in the study. Conclusion: Rifaximin may reduce the incidence of cirrhosis-related complications and the recurrence of overt HE. [ ClinicalTrials.gov identifier: NCT00298038.]" @default.
• W2893952249 created "2018-10-05" @default.
• W2893952249 creator A5044654584 @default.
• W2893952249 creator A5054702427 @default.
• W2893952249 creator A5070639714 @default.
• W2893952249 creator A5073412832 @default.
• W2893952249 date "2018-01-01" @default.
• W2893952249 modified "2023-09-27" @default.
• W2893952249 title "Rifaximin has the potential to prevent complications of cirrhosis" @default.
• W2893952249 cites W1606987360 @default.
• W2893952249 cites W1964051982 @default.
• W2893952249 cites W1969425240 @default.
• W2893952249 cites W1971689007 @default.
• W2893952249 cites W1979124801 @default.
• W2893952249 cites W1982356962 @default.
• W2893952249 cites W1996326833 @default.
• W2893952249 cites W2001137775 @default.
• W2893952249 cites W2017557941 @default.
• W2893952249 cites W2021582312 @default.
• W2893952249 cites W2033916921 @default.
• W2893952249 cites W2036052052 @default.
• W2893952249 cites W2053677150 @default.
• W2893952249 cites W2062810973 @default.
• W2893952249 cites W2079703851 @default.
• W2893952249 cites W2091059988 @default.
• W2893952249 cites W2099360240 @default.
• W2893952249 cites W2103875846 @default.
• W2893952249 cites W2113546165 @default.
• W2893952249 cites W2136883261 @default.
• W2893952249 cites W2138196119 @default.
• W2893952249 cites W2158189174 @default.
• W2893952249 cites W2159845343 @default.
• W2893952249 cites W2170325206 @default.
• W2893952249 cites W2170648583 @default.
• W2893952249 cites W2214600008 @default.
• W2893952249 cites W2289440019 @default.
• W2893952249 cites W2290314632 @default.
• W2893952249 cites W2314277440 @default.
• W2893952249 cites W2315583137 @default.
• W2893952249 cites W2328023807 @default.
• W2893952249 cites W2328533326 @default.
• W2893952249 cites W2330330313 @default.
• W2893952249 cites W2337704259 @default.
• W2893952249 cites W2344702806 @default.
• W2893952249 cites W2346278583 @default.
• W2893952249 cites W2401973160 @default.
• W2893952249 cites W2409709177 @default.
• W2893952249 cites W2508264673 @default.
• W2893952249 cites W2509621544 @default.
• W2893952249 cites W2521930054 @default.
• W2893952249 cites W2547741051 @default.
• W2893952249 cites W2558144276 @default.
• W2893952249 cites W2576419792 @default.
• W2893952249 cites W2749611858 @default.
• W2893952249 doi "https://doi.org/10.1177/1756284818800307" @default.
• W2893952249 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6166307" @default.
• W2893952249 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30283499" @default.
• W2893952249 hasPublicationYear "2018" @default.
• W2893952249 type Work @default.
• W2893952249 sameAs 2893952249 @default.
• W2893952249 citedByCount "19" @default.
• W2893952249 countsByYear W28939522492019 @default.
• W2893952249 countsByYear W28939522492020 @default.
• W2893952249 countsByYear W28939522492021 @default.
• W2893952249 countsByYear W28939522492022 @default.
• W2893952249 countsByYear W28939522492023 @default.
• W2893952249 crossrefType "journal-article" @default.
• W2893952249 hasAuthorship W2893952249A5044654584 @default.
• W2893952249 hasAuthorship W2893952249A5054702427 @default.
• W2893952249 hasAuthorship W2893952249A5070639714 @default.
• W2893952249 hasAuthorship W2893952249A5073412832 @default.
• W2893952249 hasBestOaLocation W28939522491 @default.
• W2893952249 hasConcept C126322002 @default.
• W2893952249 hasConcept C142724271 @default.
• W2893952249 hasConcept C204787440 @default.
• W2893952249 hasConcept C207103383 @default.
• W2893952249 hasConcept C27081682 @default.
• W2893952249 hasConcept C2776988256 @default.
• W2893952249 hasConcept C2777075537 @default.
• W2893952249 hasConcept C2777214474 @default.
• W2893952249 hasConcept C2777364826 @default.
• W2893952249 hasConcept C2777448540 @default.
• W2893952249 hasConcept C2778889925 @default.
• W2893952249 hasConcept C2779250428 @default.
• W2893952249 hasConcept C2779609443 @default.
• W2893952249 hasConcept C2780325230 @default.
• W2893952249 hasConcept C2780472472 @default.
• W2893952249 hasConcept C2780496750 @default.
• W2893952249 hasConcept C2911091166 @default.
• W2893952249 hasConcept C44249647 @default.
• W2893952249 hasConcept C501593827 @default.
• W2893952249 hasConcept C71924100 @default.
• W2893952249 hasConcept C86803240 @default.
• W2893952249 hasConcept C89423630 @default.
• W2893952249 hasConcept C90924648 @default.
• W2893952249 hasConceptScore W2893952249C126322002 @default.
• W2893952249 hasConceptScore W2893952249C142724271 @default.
• W2893952249 hasConceptScore W2893952249C204787440 @default.

• next